Concepts (86)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Skin Diseases, Genetic | 1 | 2019 | 4 | 0.610 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2019 | 5 | 0.610 |
Why?
|
| Dermoscopy | 2 | 2015 | 12 | 0.560 |
Why?
|
| Skin | 3 | 2014 | 224 | 0.550 |
Why?
|
| Blood Vessels | 2 | 2015 | 60 | 0.550 |
Why?
|
| Skin Diseases, Vascular | 1 | 2015 | 11 | 0.450 |
Why?
|
| Behcet Syndrome | 1 | 2014 | 5 | 0.430 |
Why?
|
| Still's Disease, Adult-Onset | 1 | 2014 | 1 | 0.430 |
Why?
|
| Propylthiouracil | 1 | 2014 | 2 | 0.430 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2014 | 2 | 0.420 |
Why?
|
| Cryoglobulins | 1 | 2014 | 5 | 0.420 |
Why?
|
| Drug Eruptions | 1 | 2014 | 9 | 0.420 |
Why?
|
| Vasculitis | 1 | 2014 | 26 | 0.420 |
Why?
|
| Edema | 1 | 2014 | 31 | 0.420 |
Why?
|
| Exanthema | 1 | 2014 | 20 | 0.420 |
Why?
|
| Erythema | 1 | 2014 | 25 | 0.420 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2014 | 14 | 0.410 |
Why?
|
| Factitious Disorders | 1 | 2013 | 1 | 0.400 |
Why?
|
| Dermatitis | 1 | 2013 | 21 | 0.390 |
Why?
|
| Cytokines | 1 | 2014 | 269 | 0.390 |
Why?
|
| Skin Neoplasms | 2 | 2019 | 225 | 0.220 |
Why?
|
| Adult | 8 | 2017 | 10030 | 0.210 |
Why?
|
| Humans | 12 | 2019 | 34562 | 0.200 |
Why?
|
| Diagnosis, Differential | 2 | 2014 | 542 | 0.180 |
Why?
|
| Female | 8 | 2017 | 21532 | 0.150 |
Why?
|
| DNA Repair | 1 | 2019 | 57 | 0.150 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 2017 | 3 | 0.130 |
Why?
|
| Thiamine | 1 | 2017 | 4 | 0.130 |
Why?
|
| Riboflavin | 1 | 2017 | 3 | 0.130 |
Why?
|
| Young Adult | 5 | 2017 | 2831 | 0.130 |
Why?
|
| Turkey | 2 | 2013 | 25 | 0.120 |
Why?
|
| Pregnancy Complications | 1 | 2017 | 115 | 0.120 |
Why?
|
| Lipids | 1 | 2017 | 267 | 0.120 |
Why?
|
| Nevus | 1 | 2015 | 17 | 0.110 |
Why?
|
| Signal Transduction | 1 | 2019 | 771 | 0.110 |
Why?
|
| Maneb | 1 | 2014 | 2 | 0.110 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2014 | 2 | 0.110 |
Why?
|
| Antithyroid Agents | 1 | 2014 | 1 | 0.110 |
Why?
|
| Patch Tests | 1 | 2014 | 8 | 0.110 |
Why?
|
| Melanoma | 1 | 2015 | 170 | 0.100 |
Why?
|
| Alkalies | 1 | 2013 | 2 | 0.100 |
Why?
|
| Wood | 1 | 2013 | 3 | 0.100 |
Why?
|
| Burns, Chemical | 1 | 2013 | 8 | 0.100 |
Why?
|
| Pruritus Ani | 1 | 2013 | 1 | 0.100 |
Why?
|
| Antipruritics | 1 | 2013 | 4 | 0.100 |
Why?
|
| Adolescent | 4 | 2014 | 3805 | 0.100 |
Why?
|
| Industry | 1 | 2013 | 16 | 0.100 |
Why?
|
| Motor Vehicles | 1 | 2013 | 26 | 0.100 |
Why?
|
| Tacrolimus | 1 | 2013 | 68 | 0.100 |
Why?
|
| Occupational Diseases | 1 | 2013 | 82 | 0.090 |
Why?
|
| Male | 6 | 2014 | 20740 | 0.090 |
Why?
|
| Immunosuppressive Agents | 1 | 2013 | 251 | 0.090 |
Why?
|
| Dermatitis, Atopic | 1 | 2013 | 103 | 0.090 |
Why?
|
| Skin Diseases | 1 | 2013 | 149 | 0.090 |
Why?
|
| Inflammation | 1 | 2014 | 557 | 0.080 |
Why?
|
| Child | 2 | 2014 | 2614 | 0.080 |
Why?
|
| Occupational Exposure | 1 | 2013 | 237 | 0.080 |
Why?
|
| Hospitalization | 1 | 2013 | 500 | 0.080 |
Why?
|
| Middle Aged | 5 | 2014 | 12726 | 0.070 |
Why?
|
| Retrospective Studies | 1 | 2013 | 3825 | 0.050 |
Why?
|
| Lipid Metabolism | 1 | 2017 | 113 | 0.030 |
Why?
|
| Random Allocation | 1 | 2017 | 257 | 0.030 |
Why?
|
| Aged | 3 | 2014 | 11022 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2017 | 169 | 0.030 |
Why?
|
| Melanocytes | 1 | 2014 | 8 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2014 | 24 | 0.030 |
Why?
|
| Epidermis | 1 | 2014 | 30 | 0.030 |
Why?
|
| Antigens, CD34 | 1 | 2014 | 61 | 0.030 |
Why?
|
| Hair Follicle | 1 | 2014 | 8 | 0.030 |
Why?
|
| Microvessels | 1 | 2014 | 31 | 0.030 |
Why?
|
| Pregnancy | 1 | 2017 | 1069 | 0.030 |
Why?
|
| Wettability | 1 | 2013 | 2 | 0.030 |
Why?
|
| Petrolatum | 1 | 2013 | 4 | 0.020 |
Why?
|
| Emollients | 1 | 2013 | 11 | 0.020 |
Why?
|
| Necrosis | 1 | 2013 | 55 | 0.020 |
Why?
|
| Medicine, Traditional | 1 | 2013 | 22 | 0.020 |
Why?
|
| Administration, Cutaneous | 1 | 2013 | 119 | 0.020 |
Why?
|
| Administration, Topical | 1 | 2013 | 146 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 526 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2017 | 2463 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2014 | 1355 | 0.020 |
Why?
|
| Rats | 1 | 2014 | 1946 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 2353 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 4157 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2013 | 3623 | 0.010 |
Why?
|
| Animals | 1 | 2014 | 8579 | 0.010 |
Why?
|